Breast Center, University Hospital Basel, Basel, Switzerland; University of Basel, Basel, Switzerland.
Breast Center, University Hospital Basel, Basel, Switzerland; University of Basel, Basel, Switzerland.
Breast. 2017 Aug;34 Suppl 1:S78-S81. doi: 10.1016/j.breast.2017.06.033. Epub 2017 Jul 6.
Oncoplastic breast conserving surgery is increasingly used to treat patients with breast cancer. In the absence of randomized data, a large body of observational evidence consistently indicates low rates of recurrence and high rates of survival, but points to a higher rate of complications compared to conventional breast conserving surgery. Established goals of oncoplastic breast conserving surgery are to broaden the indication for breast conservation towards larger tumors, and to improve esthetic outcomes. The benefit from the patient's perspective, however, remains largely to be confirmed. There is a growing demand to standardize various aspects of oncoplastic breast conserving surgery for implementation in clinical research and practice. Several classification systems and outcomes measurement tools have been proposed, but to the present day, none of them has achieved international acceptance.
肿瘤整形保乳术越来越多地用于治疗乳腺癌患者。在缺乏随机数据的情况下，大量观察性证据一致表明复发率较低且生存率较高，但与传统保乳术相比，并发症发生率较高。肿瘤整形保乳术的既定目标是扩大保乳的适应证，以治疗更大的肿瘤，并改善美容效果。然而，患者受益在很大程度上仍有待证实。人们越来越要求对肿瘤整形保乳术的各个方面进行标准化，以便在临床研究和实践中实施。已经提出了几种分类系统和结果测量工具，但迄今为止，没有一种得到国际认可。
